PartnershipMay 14, 2026, 08:32 AM

Neuronetics Partners with ANT Neuro to Enhance NeuroStar TMS

AI Summary

Neuronetics, Inc. announced a strategic partnership with ANT Neuro to integrate ANT Neuro’s visor2™ neuronavigation system with its NeuroStar® Advanced Therapy System. This collaboration aims to enhance treatment visualization, consistency, and personalization for Transcranial Magnetic Stimulation (TMS) workflows by combining NeuroStar's contact sensing technology with visor2™'s real-time spatial tracking and 3D visualization. The partnership will be showcased at upcoming industry meetings, with a broader rollout anticipated in the second half of 2026.

Key Highlights

Neuronetics partnered with ANT Neuro to enhance NeuroStar Advanced Therapy System.
Integrates ANT Neuro’s FDA-cleared visor2™ neuronavigation system.
Aims to enhance TMS treatment visualization, consistency, and personalization.
Collaboration to be showcased at May and June industry meetings.
Broader rollout of the integrated system planned for 2nd half of 2026.

View SEC Filing

STIM

Medical/Dental Instruments

Neuronetics, Inc.

Price Impact